3034:HK:HK-CSOP Metaverse Concept ETF (HKD)

ETF | Others |

Last Closing

USD 8.875

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

-0.30 (-1.61%)

USD 131.28B
2840:HK SPDR® Gold Shares

+21.00 (+1.21%)

USD 59.08B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

-1.12 (-1.70%)

USD 21.03B
2823:HK iShares FTSE A50 China

+0.01 (+0.08%)

USD 14.95B
3188:HK ChinaAMC CSI 300 Index ETF

+0.40 (+1.04%)

USD 14.60B
83188:HK ChinaAMC CSI 300 Index ETF

+0.24 (+0.67%)

USD 13.48B
2801:HK iShares Core MSCI China ETF

-0.28 (-1.47%)

USD 12.97B
7226:HK CSOP Hang Seng TECH Index Dail..

-0.09 (-2.64%)

USD 10.25B
3067:HK iShares Hang Seng TECH ETF

-0.12 (-1.49%)

USD 9.22B

ETFs Containing 3034:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.25% 81% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.25% 80% B- 78% C+
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike